Search | VHL Regional Portal

A metastatic, cutaneous mucinous carcinoma revealed by the 16α-¹⁸F-fluoroestradiol (¹⁸F-FES) PET/CT scan and successfully treated by hormonotherapy: Description of a case report.

Longo, Raffaele; Mammoud, Sinan Ben; Ribal, Romane; Dadoun, Alexandre; Egea, Julie; Plastino, Francesca; Legros, Pierre-Olivier; Marcon, Nathalie; Liegeon, Anne Laure; Campitiello, Marco.

J Dermatol ; 51(6): e205-e206, 2024 Jun.

Article in English | MEDLINE | ID: mdl-38216980

Subject(s)

Adenocarcinoma, Mucinous , Positron Emission Tomography Computed Tomography , Skin Neoplasms , Aged , Female , Humans , Adenocarcinoma, Mucinous/drug therapy , Adenocarcinoma, Mucinous/diagnostic imaging , Adenocarcinoma, Mucinous/secondary , Adenocarcinoma, Mucinous/pathology , Antineoplastic Agents, Hormonal/therapeutic use , Estradiol/therapeutic use , Estradiol/analogs & derivatives , Estradiol/administration & dosage , Fluorine Radioisotopes , Skin Neoplasms/drug therapy , Skin Neoplasms/pathology , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/diagnosis , Treatment Outcome

Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer? Results of a retrospective study.

Longo, Raffaele; Thiebaut, Victoire; Legros, Pierre-Olivier; Campitiello, Marco; Plastino, Francesca; Goetz, Christophe; Margineanu, Bogdan; Pujois, Julie; Gunther, Michel; Egea, Julie; Wendel, Chloé.

Acta Oncol ; 61(11): 1394-1399, 2022 11.

Article in English | MEDLINE | ID: mdl-36228137

Subject(s)

Breast Neoplasms , Humans , Female , Breast Neoplasms/drug therapy , Retrospective Studies , Trastuzumab/therapeutic use , Receptor, ErbB-2 , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Neoadjuvant Therapy

HER2-positive metastatic, parotid salivary duct carcinoma treated with a trastuzumab/pertuzumab-based chemotherapy: A case report.

Longo, Raffaele; Legros, Pierre-Olivier; Talbi, Marouane; Wagner, Marc; Paraschiv, Elena-Adinisia; Campitiello, Marco; Plastino, Francesca; Rozzi, Antonio.

Clin Case Rep ; 8(12): 2878-2882, 2020 Dec.

Article in English | MEDLINE | ID: mdl-33363842

ABSTRACT

This case highlights the rare entity, salivary duct carcinoma (SDC), which is difficult to diagnose and manage. It is the first published case of a metastatic, HER2-positive parotid SDC successfully treated by a dual anti-HER2 treatment associated to a chemotherapy.

Subject(s)

Subject(s)

ABSTRACT

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL